BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 24552833)

  • 1. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.
    Jeltsch M; Jha SK; Tvorogov D; Anisimov A; Leppänen VM; Holopainen T; Kivelä R; Ortega S; Kärpanen T; Alitalo K
    Circulation; 2014 May; 129(19):1962-71. PubMed ID: 24552833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
    Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
    J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
    Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
    Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain.
    Roukens MG; Peterson-Maduro J; Padberg Y; Jeltsch M; Leppänen VM; Bos FL; Alitalo K; Schulte-Merker S; Schulte D
    Circ Res; 2015 May; 116(10):1660-9. PubMed ID: 25814692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.
    Bos FL; Caunt M; Peterson-Maduro J; Planas-Paz L; Kowalski J; Karpanen T; van Impel A; Tong R; Ernst JA; Korving J; van Es JH; Lammert E; Duckers HJ; Schulte-Merker S
    Circ Res; 2011 Aug; 109(5):486-91. PubMed ID: 21778431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
    Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
    Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis.
    Le Guen L; Karpanen T; Schulte D; Harris NC; Koltowska K; Roukens G; Bower NI; van Impel A; Stacker SA; Achen MG; Schulte-Merker S; Hogan BM
    Development; 2014 Mar; 141(6):1239-49. PubMed ID: 24523457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The YAP-TEAD4 complex promotes tumor lymphangiogenesis by transcriptionally upregulating CCBE1 in colorectal cancer.
    Song J; Dang X; Shen X; Liu Y; Gu J; Peng X; Huang Z; Hong W; Cui L; Liu CY
    J Biol Chem; 2023 Apr; 299(4):103012. PubMed ID: 36781122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical E2fs control lymphangiogenesis through transcriptional regulation of Ccbe1 and Flt4.
    Weijts BG; van Impel A; Schulte-Merker S; de Bruin A
    PLoS One; 2013; 8(9):e73693. PubMed ID: 24069224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of ADAMTS3 activity causes Hennekam lymphangiectasia-lymphedema syndrome 3.
    Brouillard P; Dupont L; Helaers R; Coulie R; Tiller GE; Peeden J; Colige A; Vikkula M
    Hum Mol Genet; 2017 Nov; 26(21):4095-4104. PubMed ID: 28985353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Lymphangiogenic Factor CCBE1 Promotes Angiogenesis and Tumor Growth in Colorectal Cancer.
    Ding W; Tang W; Zhi J
    Curr Mol Med; 2022; 22(9):819-825. PubMed ID: 34819004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
    Tammela T; He Y; Lyytikkä J; Jeltsch M; Markkanen J; Pajusola K; Ylä-Herttuala S; Alitalo K
    Circ Res; 2007 May; 100(10):1468-75. PubMed ID: 17478733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCBE1 is required for coronary vessel development and proper coronary artery stem formation in the mouse heart.
    Bonet F; Pereira PNG; Bover O; Marques S; Inácio JM; Belo JA
    Dev Dyn; 2018 Oct; 247(10):1135-1145. PubMed ID: 30204931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
    J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.